NPCE

Neuropace Inc

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
LIFE SCIENCES

Prices are adjusted according to historical splits.

Neuropace Inc Stock Price

Vitals

Today's Low:
$2.3400
Today's High:
$2.8800
Open Price:
$2.7500
52W Low:
$2.34
52W High:
$17.8
Prev. Close:
$2.8700
Volume:
18800

Company Statistics

Market Cap.:
$0.058 billion
Book Value:
2.132
Revenue TTM:
$0.043 billion
Operating Margin TTM:
-83.9%
Gross Profit TTM:
$0.033 billion
Gross Profit TTM:
$0.033 billion
Profit Margin:
-100%
Return on Assets TTM:
-17%
Return on Equity TTM:
-60.7%

Company Profile

Neuropace Inc had its IPO on 2021-04-22 under the ticker symbol NPCE.

The company operates in the LIFE SCIENCES sector and SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry. Neuropace Inc has a staff strength of 0 employees.

Stock update

Shares of Neuropace Inc opened at $2.75 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $2.34 - $2.88, and closed at $2.34.

This is a -18.47% slip from the previous day's closing price.

A total volume of 18,800 shares were traded at the close of the day’s session.

In the last one week, shares of Neuropace Inc have slipped by -22%.

Neuropace Inc's Key Ratios

Neuropace Inc has a market cap of $0.058 billion, indicating a price to book ratio of 1.409 and a price to sales ratio of 1.355.

In the last 12-months Neuropace Inc’s revenue was $0.043 billion with a gross profit of $0.033 billion and an EBITDA of $-0.036 billion. The EBITDA ratio measures Neuropace Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Neuropace Inc’s operating margin was -83.9% while its return on assets stood at -17% with a return of equity of -60.7%.

In Q2, Neuropace Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 19.2%.

Neuropace Inc’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
None

Its diluted EPS in the last 12-months stands at $-1.712 per share while it has a forward price to earnings multiple of - and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Neuropace Inc’s profitability.

Neuropace Inc stock is trading at a EV to sales ratio of 0.916 and a EV to EBITDA ratio of -1.159. Its price to sales ratio in the trailing 12-months stood at 1.355.

Neuropace Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Neuropace Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Neuropace Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Neuropace Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Neuropace Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Neuropace Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$2.34
52-Week High
$17.8
52-Week Low
$2.34
Analyst Target Price
$5.83

Neuropace Inc stock is currently trading at $2.34 per share. It touched a 52-week high of $17.8 and a 52-week low of $17.8. Analysts tracking the stock have a 12-month average target price of $5.83.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Neuropace Inc

The stock symbol (also called stock or share ticker) of Neuropace Inc is NPCE

The IPO of Neuropace Inc took place on 2021-04-22

Similar Industry Stocks (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS)

Last Price
Chg
Chg%
$15.34
-0.87
-5.37%
$43.12
-1.01
-2.29%
$211.97
-8.12
-3.69%
$73.53
-1.73
-2.3%
$0.42
0
+0.33%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

NeuroPace, Inc. is a medical device company in the United States. The company is headquartered in Mountain View, California.

Address

455 N. BERNARDO AVENUE, MOUNTAIN VIEW, CA, US